REGN
Regeneron Pharmaceuticals, Inc.
Stock
$735.20+0.39 (+0.05%)Close Oct 2, 2026
- Total assets, 2025
- $40.6B
- YoY, 2025
- +7.4%
- 5-year CAGR
- +18.8%
- 10-year CAGR
- +21.9%
Total assets
Total assets by fiscal year
| Period | Total assets | YoY |
|---|---|---|
| 2025 | $40.6B | +7.4% |
| 2024 | $37.8B | +14.1% |
| 2023 | $33.1B | +13.2% |
| 2022 | $29.2B | +14.9% |
| 2021 | $25.4B | +48.2% |
| 2020 | $17.2B | +15.9% |
| 2019 | $14.8B | +26.2% |
| 2018 | $11.7B | +33.9% |
| 2017 | $8.8B | +25.7% |
| 2016 | $7.0B | +24.3% |
| 2015 | $5.6B | +46.2% |
| 2014 | $3.8B | +30.0% |
| 2013 | $3.0B | +41.8% |
| 2012 | $2.1B | +57.2% |
| 2011 | $1.3B | +21.5% |
| 2010 | $1.1B | +47.0% |
| 2009 | $741M | — |